2025 年 03 月 13 日 公司研究 评级：买入(维持) | 研究所： | | | | --- | --- | --- | | 证券分析师： | | 马川琪 S0350523050001 | | | | macq@ghzq.com.cn | | 联系人 | ： | 刘毅 S0350123090035 | | | | liuy23@ghzq.com.cn | [Table_Title] Q4 收入超指引高段，Non-GAAP 经营利润持续 创新高 ——万物新生（RERE）2024Q4 财报点评报告 | | | 1M | 3M | 12M | | | --- | --- | --- | --- | --- | --- | | 万物新生 | | 13.73% | 15.23% | 130.46% | | | 标普 | 500 | -8.18% | -8.42% | 7.67% | 300 | | 市场数据 | 2025/03/12 | | --- | --- | | 当前价格（美元） | 3.33 | | 周价格区间（美元） 52 | 1.50-3.70 | | 总市值（百万美元） | 730.85 | | ...

[Table_Title] 烯烃量利双增，规划新疆煤制烯烃项目 ——宝丰能源（600989）2024 年报点评 最近一年走势 | 相对沪深 300 | 表现 | | 2025/03/12 | | --- | --- | --- | --- | | 表现 | 1M | 3M | 12M | | 宝丰能源 | 0.0% | 4.5% | 13.4% | | 沪深 300 | 0.2% | -2.5% | 9.2% | | 市场数据 | | | 2025/03/12 | | 当前价格（元） | | | 17.00 | | 52 周价格区间（元） | | | 14.03-19.07 | | 总市值（百万） | | | 124,667.12 | | 流通市值（百万） | | | 124,667.12 | | 总股本（万股） | | | 733,336.00 | | 流通股本（万股） | | | 733,336.00 | | 日均成交额（百万） | | | 753.45 | | 近一月换手（%） | | | 0.38 | 相关报告 2025 年 03 月 13 日 公司研究 评级：买入(维持) 研究所： 证券分析师： 李 ...

2025 年 03 月 12 日 公司研究 评级：增持(维持) 研究所： 证券分析师： 罗琨 S0350522110003 luok@ghzq.com.cn [Table_Title] 规模效应凸显构筑高壁垒，龙头坐享智驾行业红利 ——禾赛（HSAI）2024 年业绩点评 7,100-7,400 万美元），同比增长约 45%-50%。 | 相对纳斯达克指数表现 | | | 2025/3/11 | | --- | --- | --- | --- | | 表现 | 1M | 3M | 12M | | 禾赛 | 40.90% | 106.70% | 318.06% | | 纳斯达克 100 | -10.94% | -9.32% | 7.54% | | 市场数据 | | | 2025/03/11 | | 当前价格（美元） | | | 24.08 | | 52 周价格区间（美元） | | | 15.29-24.18 | | 总市值（百万美元） | | | 3,069.68 | | 流通市值（百万美元） | | | 3,069.68 | | 总股本（万股） | | | 12,748 | | 流通股本（万股） | | | ...

Core Insights - The report emphasizes the transition of public REITs in China from policy-driven growth to value-based investment strategies, highlighting the significant increase in the diversity of underlying assets and the market's maturation [1][6][8] - The total issuance of public REITs reached 29 in 2024, with a total fundraising scale of 65.5 billion yuan, pushing the market's total scale to over 180 billion yuan [3][9] - The report identifies structural opportunities within the REITs market, particularly in consumer and logistics REITs, which are expected to outperform due to market-driven pricing mechanisms [3][29] Market Review: Policy Framework and Cycle Evolution - Since the pilot launch of infrastructure REITs in April 2020, the policy framework has evolved from initial trials to a comprehensive system that includes issuance review, asset operation, and financial treatment [6][7] - The policy focus has shifted towards expanding the pilot scope and improving supporting regulations, with significant developments occurring from 2021 to 2023 [7][8] - By February 2025, the cumulative number of public REITs listed reached 65, with a total market size of 171.1 billion yuan, marking a more than fivefold increase from the initial issuance scale in 2021 [9][11] Recent Trends - The report notes a significant increase in subscription enthusiasm for public REITs, with a record public investor subscription multiple of 1192 times for a recent offering [19] - The strategic investor participation rate has risen from 67.4% in 2021 to 76.3% in 2024, indicating a growing preference for long-term asset allocation [19][28] - The report highlights a decoupling between the recent price increases in REITs and the underlying revenue performance, suggesting that market dynamics may be increasingly driven by policy expectations rather than fundamental performance [29] Underlying Assets: Macro Characteristics and Future Outlook - Consumer infrastructure is identified as a direct beneficiary of consumption recovery, while logistics REITs are driven by e-commerce and retail demand [4][19] - The report discusses the resilience of affordable rental housing REITs, which maintain high occupancy rates but exhibit limited income elasticity due to rent control policies [4][19] - The energy infrastructure and ecological protection sectors are noted as sensitive to interest rate changes, impacting their revenue stability [4][19] Valuation and Performance Analysis - The report indicates a divergence in valuation within the REITs market, with 39 out of 61 listed REITs having a price-to-value (PV) multiple exceeding 1, suggesting potential premium risks for some projects [3][29] - The overall revenue of the REITs market has shown a declining trend, with year-on-year revenue growth rates of -4.65% and -5.14% recorded in the third and fourth quarters of 2024, respectively [29][30] - Specific sectors, such as logistics and park infrastructure, exhibit significant performance variability, with some projects achieving substantial revenue growth through expansion efforts [29][30]

证券研究报告 2025年03月11日 乘用车 理想汽车（2015.HK）专题报告：从汽车到人工智能，公司 有望重估 评级：买入(上调) -57% -35% -13% 8% 30% 52% 2024/03/11 理想汽车-W 恒生指数 市场数据 2025/03/11 当前价格（港元） 113.00 52周价格区间（港元） 68.65-156.70 总市值（百万元） 225,435.61 流通市值（百万元） 225,435.61 总股本（万股） 199,500.54 流通股本（万股） 199,500.54 日均成交额（百万元） 2,374.99 近一月换手（%） 1.46 相关报告 | 《理想汽车-W（02015）2024Q3财报点评：2024Q3业绩环比增长，智驾持续加 | | --- | | 速（增持）*乘用车*戴畅》——2024-11-05 | | 《理想汽车-W（02015）2024Q2财报点评：2024Q2业绩环比增长，智驾持续加 | | 速（增持）*乘用车*戴畅》——2024-09-02 | | 《理想汽车-W（02015）2024Q1点评报告：2024Q1销量业绩环比承压，新品上 | | 市静待反弹 ...

2025 年 03 月 12 日 晨会纪要 研究所： 证券分析师： 余春生 S0350513090001 yucs@ghzq.com.cn [Table_Title] 晨会纪要 ——2025 年第 40 期 观点精粹: 证券研究报告 1、最新报告摘要 1.1、行稳百亿路，缘启新篇章--今世缘/白酒Ⅱ(603369/213405) 公司深度研 究 分析师：刘洁铭 S0350521110006 联系人：郝天宇 S0350124060016 投资要点: 深耕"缘"文化，增长势能强劲。今世缘是中国白酒上市公司十强企业，拥有"国缘"、"今世缘"、"高沟"三 大品牌，其中核心产品国缘系列定位次高端白酒市场。公司深耕"缘"文化营销，通过多场景强化品牌认知， 立足江苏基地市场向周边辐射。2023 年公司营收顺利实现跨越百亿元，2024 年前三季度公司业绩增速在上市 酒企中排名前列，体现出强劲的增长势能。 江苏白酒市场结构领先，公司平衡量价从容增长，潜力市场空间较大。1）江苏白酒消费氛围浓厚、消费量较 大。江苏白酒市场规模全国第二，其中苏北酒风豪迈，苏中、苏南经济水平较好，用酒档次较高。在上轮白酒 景气周期中引导省内产品率先升 ...

Investment Rating - The report maintains a "Recommended" rating for the humanoid robot industry, indicating a favorable outlook for investment opportunities in this sector [1][62]. Core Insights - The report highlights that dexterous hands, as end-effectors of robots, can be classified based on appearance, drive methods, and transmission methods. The mainstream types currently available in the market are primarily categorized as "biomimetic" combined with "motor" and either "linkage," "tendon," or "gear" transmission [6][7]. - The report discusses various drive solutions, including external wrist motors, finger root motors, and internal motors at finger joints, emphasizing the trade-off between the number of motors and degrees of freedom, where more motors lead to higher costs [6][8]. - It provides a detailed analysis of transmission methods, comparing linkage, tendon, and gear systems, each with its advantages and disadvantages in terms of stiffness, load capacity, manufacturing complexity, and cost [6][20]. - The report identifies key players in the dexterous hand market, including micro-motor suppliers and dexterous hand manufacturers, and suggests monitoring specific companies for investment opportunities [6][62]. Summary by Sections Section 1: Dexterous Hand Analysis - Dexterous hands are categorized based on appearance (grippers vs. biomimetic hands), drive methods (motor, hydraulic, pneumatic, artificial muscle), and transmission methods (gear, linkage, tendon) [7][8]. - The report emphasizes that the drive method of electric motors is the mainstream choice for biomimetic dexterous hands, with various configurations available depending on design and application [10][12]. Section 2: Patent Analysis - The report dissects patents from various companies, revealing that the dexterous hands primarily utilize biomimetic designs with at least three fingers and nine degrees of freedom, equipped with advanced sensor systems [28][29]. - It highlights Tesla's dexterous hand design, which incorporates built-in motors and gear systems for finger movement, showcasing innovative wiring methods for tendon-driven fingers [31][35]. Section 3: Related Companies and Investment Opportunities - The report lists several key companies in the humanoid robot sector, including micro-motor suppliers like Zhaowei Electromechanical and Mingzhi Electric, tendon and material suppliers like Nanshan Zhishang, and sensor suppliers like Keli Sensor [62][63]. - It provides financial forecasts for these companies, indicating their market capitalization and expected earnings for the coming years, which can guide investment decisions [63].

| | | [Table_Title] 行稳百亿路，缘启新篇章 联系人 ： 郝天宇 S0350124060016 haoty@ghzq.com.cn ——今世缘（603369）公司深度研究 最近一年走势 | 相对沪深 300 | 表现 | | 2025/03/10 | | --- | --- | --- | --- | | 表现 | 1M | 3M | 12M | | 今世缘 | 22.0% | 7.6% | 3.7% | | 沪深 300 | 1.0% | -1.4% | 11.2% | | 市场数据 | | | 2025/03/10 | | 当前价格（元） | | | 53.44 | | 周价格区间（元） 52 | | | 35.35-61.05 | | 总市值（百万） | | | 66,628.99 | | 流通市值（百万） | | | 66,628.99 | | 总股本（万股） | | | 124,680.00 | | 流通股本（万股） | | | 124,680.00 | | 日均成交额（百万） | | | 286.07 | | 近一月换手（%） | | | 0.73 | 相关报告 《今世缘（603 ...

Investment Rating - The report maintains a "Buy" rating for the company [1][11]. Core Views - The company's revenue and profit growth for 2024 exceeded Bloomberg consensus expectations, driven by increases in product sales and advertising revenue [7]. - The company has strengthened its self-operated advantages and enhanced the competitiveness of its online platform and instant retail business, achieving complementary advantages across three business models [7]. - The daily average transaction amount reached 1,164.74 million HKD, with over 1.84 million active users by the end of 2024 [7][8]. Financial Performance Summary - For 2024, the company reported revenue of 582 billion RMB, a year-on-year increase of 8.6%, with a gross profit of 133 billion RMB and a gross margin of 22.9% [5][10]. - Adjusted operating profit was 2.6 billion RMB, corresponding to an operating margin of 4.5%, while adjusted net profit reached 4.8 billion RMB, reflecting a year-on-year growth of 15.9% [5][10]. - The company expects revenues of 660 billion RMB in 2025, 741 billion RMB in 2026, and 820 billion RMB in 2027, with adjusted net profits of 4.5 billion RMB, 4.9 billion RMB, and 5.4 billion RMB respectively [9][10]. Market Position and User Engagement - The company has expanded its online medical insurance payment capabilities, significantly enhancing user conversion rates and reducing medication costs for users [7]. - The AI health assistant "KangKang" has served over 30 million users, achieving a problem-solving rate of 70% [8].

Investment Rating - The report maintains a "Buy" rating for the company [1][12] Core Insights - The company achieved a revenue of 13.148 billion yuan in 2024, a year-on-year decrease of 8.4%, while the net profit attributable to shareholders was 1.911 billion yuan, an increase of 4.1% [4][11] - In Q4 2024, the company reported a revenue of 5.106 billion yuan, down 22.57% year-on-year, but the net profit attributable to shareholders increased by 5.16% to 1.142 billion yuan [4][5] - The operating cash flow for Q4 2024 was 4 billion yuan, reflecting a significant year-on-year increase of 50% [4][5] Financial Performance - The company's gross profit margin for 2024 was 29.16%, up 2.9 percentage points year-on-year, with a net profit margin of 15.16%, an increase of 2.08 percentage points [5] - In Q4 2024, the gross profit margin improved to 32.86%, a rise of 6.15 percentage points year-on-year, with a net profit margin of 23.27%, up 6.75 percentage points [5] Strategic Developments - The company is restructuring its core computing business and deepening its intelligent computing services, integrating AI scenarios into its offerings [5][6] - The company is enhancing its capabilities in high-end computing, cloud computing, and computing services, with a focus on AI training and inference [6][8] Ecosystem Expansion - The company is actively extending its computing ecosystem, investing in high-quality assets such as Haiguang Information and Zhuhai Data Creation [9] - Haiguang Information reported a revenue of 9.16 billion yuan in 2024, a year-on-year increase of 52.4% [9] Earnings Forecast - The company is projected to achieve revenues of 15.663 billion yuan in 2025, 19.837 billion yuan in 2026, and 25.417 billion yuan in 2027, with corresponding net profits of 2.846 billion yuan, 3.799 billion yuan, and 5.247 billion yuan respectively [10][11]